The legacy success of copyright’s flagship drug has undeniably shaped the pharmaceutical landscape. However, wagering in companies heavily dependent on copycat drugs and the declining patent exclusivity https://single-bookmark.com/story21400421/the-blue-pill-and-pharma-a-uncertain-venture